Review: Prospects for ARB in the next five years
- 1 December 2001
- journal article
- review article
- Published by Hindawi Limited in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 2 (4), 215-218
- https://doi.org/10.3317/jraas.2001.034
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Study on COgnition and Prognosis in the Elderly (SCOPE)Blood Pressure, 1999
- Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and designJournal of Cardiac Failure, 1999
- Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) RegistryEuropean Heart Journal, 1999
- Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial designThe American Journal of Cardiology, 1999
- The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) Trial of Cardiovascular Events in Hypertension. Rationale and DesignBlood Pressure, 1998
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1995
- Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failureJournal of the American College of Cardiology, 1995
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987